Literature DB >> 12635944

Causes of death in polymyalgia rheumatica. A prospective longitudinal study of 315 cases and matched population controls.

Geirmund Myklebust1, Tom Wilsgaard, Bjarne Koster Jacobsen, Jan Tore Gran.   

Abstract

OBJECTIVE: To determine causes of death in patients with pure polymyalgia rheumatica (PMR) compared to matched population controls.
METHODS: In a population based study from 1987-1997, 315 patients were diagnosed with PMR. The patients were each randomly assigned four population controls, totally 1,260 controls. The date and causes of death were identified from the data files at Statistics Norway up to the end of 1997.
RESULTS: A total of 65 cases (20.6%) with PMR died compared to 338 (26.8%) among the controls (mortality rate ratio (MRR) = 0.73, 95% CI 0.56-0.97, p = 0.03). No statistically significant difference was found between patients and controls with regard to mortality from coronary heart disease or stroke (MRR=0.78, 95% CI 0.52-1.18), cancer (MRR = 0.59, 95% CI 0.30-1.17), and other causes (MRR=0.75, 95% CI 0.48-1.17).
CONCLUSION: The increased survival found in patients with PMR could not be explained by reduction in any particular cause of death.

Entities:  

Mesh:

Year:  2003        PMID: 12635944     DOI: 10.1080/03009740310000382

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

1.  The epidemiology of polymyalgia rheumatica in primary care: a research protocol.

Authors:  Sara Muller; Samantha Hider; Toby Helliwell; Joanne Bailey; Kevin Barraclough; Louise Cope; Bhaskar Dasgupta; Rebecca Foskett; Rhian Hughes; Zoe Mayson; Charlotte Purcell; Edward Roddy; Simon Wathall; Irena Zwierska; Christian D Mallen
Journal:  BMC Musculoskelet Disord       Date:  2012-06-15       Impact factor: 2.362

Review 2.  Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient.

Authors:  Marcin Milchert; Marek Brzosko
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

3.  Risk of vascular events in patients with polymyalgia rheumatica.

Authors:  Adam T Hancock; Christian D Mallen; Sara Muller; John Belcher; Edward Roddy; Toby Helliwell; Samantha L Hider
Journal:  CMAJ       Date:  2014-07-28       Impact factor: 8.262

4.  Comorbidities in polymyalgia rheumatica: a systematic review.

Authors:  Richard Partington; Toby Helliwell; Sara Muller; Alyshah Abdul Sultan; Christian Mallen
Journal:  Arthritis Res Ther       Date:  2018-11-20       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.